Galectin Therapeutics Inc. (NASDAQ:GALT)

CAPS Rating: 1 out of 5

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 7/25/2012 10:02:04 AM : Underperform Start Price: $3.05 GALT Score: +32.31

take any recent gains now or you will develop groans to replace the gains

Featured Broker Partners


Advertisement